# Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

> **NCT00003661** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 3 (actual)

## Conditions studied

- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- Neuroblastoma

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** busulfan
- **DRUG:** cyclosporine
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003661
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** 1999-11
- **Final completion:** 2006-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2011-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003661, "Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*